| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... Lancet 384 (9939), 241-248, 2014 | 1119 | 2014 |
| Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ... Aids 24 (11), 1667-1678, 2010 | 522 | 2010 |
| Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... J Infect Dis 207 (9), 1359-1369, 2013 | 369 | 2013 |
| Serious fatal and nonfatal non-AIDS-defining illnesses in Europe A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010 | 339 | 2010 |
| Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ... Aids 25 (10), 1305-1315, 2011 | 246 | 2011 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 223 | 2013 |
| Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe V Soriano, A Mocroft, J Rockstroh, B Ledergerber, B Knysz, ... Journal of Infectious Diseases 198 (9), 1337-1344, 2008 | 211 | 2008 |
| Measuring quality of life among people living with HIV: a systematic review of reviews V Cooper, J Clatworthy, R Harding, J Whetham, E Consortium Health and quality of life outcomes 15 (1), 1-20, 2017 | 205 | 2017 |
| Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline … A Mocroft, JD Lundgren, M Ross, CA Fux, P Reiss, O Moranne, P Morlat, ... Lancet HIV 3 (10), e23-32, 2016 | 205 | 2016 |
| Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study) AK Sullivan, D Raben, J Reekie, M Rayment, A Mocroft, S Esser, A Leon, ... PloS one 8 (1), e52845, 2013 | 205 | 2013 |
| Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies J Reekie, C Kosa, F Engsig, AA Monforte, A Wiercinska‐Drapalo, ... Cancer 116 (22), 5306-5315, 2010 | 191 | 2010 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus V Puro, G De Carli, S Cicalini, F Soldani, U Balslev, J Begovac, ... Eurosurveillance 10 (10), 11-12, 2005 | 177 | 2005 |
| The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology JD Kowalska, N Friis-Møller, O Kirk, W Bannister, A Mocroft, C Sabin, ... Epidemiology 22 (4), 516-523, 2011 | 169 | 2011 |
| Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. AC Achhra, A Mocroft, P Reiss, C Sabin, L Ryom, S de Wit, CJ Smith, ... HIV Med 17 (4), 255-268, 2016 | 166 | 2016 |
| Loss to follow‐up in an international, multicentre observational study A Mocroft, O Kirk, P Aldins, A Chies, A Blaxhult, N Chentsova, N Vetter, ... HIV medicine 9 (5), 261-269, 2008 | 153 | 2008 |
| Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. A Mocroft, JD Lundgren, M Ross, M Law, P Reiss, O Kirk, C Smith, ... PLoS Med 12 (3), e1001809, 2015 | 139 | 2015 |
| Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS- defining conditions are created equal. SM Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne ... Clinical infectious diseases 48 (8), 1138-1151, 2009 | 138 | 2009 |
| mHealth interventions to support self-management in HIV: a systematic review V Cooper, J Clatworthy, J Whetham, EmERGE Consortium The open AIDS journal 11, 119, 2017 | 136 | 2017 |
| Guidelines for the diagnosis and management of neurological complications of HIV infection P Portegies, L Solod, P Cinque, A Chaudhuri, J Begovac, I Everall, ... European Journal of Neurology 11 (5), 297-304, 2004 | 135 | 2004 |
